Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning.
about
Nanofibrous scaffolds in biomedical applicationsDevelopment of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinningMonitoring tablet surface roughness during the film coating processEngineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration.Cyclodextrin-based pharmaceutics: past, present and future.Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.Nanofibers and their applications in tissue engineeringSolid dispersions in the form of electrospun core-sheath nanofibers.A short review: Recent advances in electrospinning for bone tissue regenerationThe role of electrospinning in the emerging field of nanomedicine.Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.Nanoparticles and nanofibers for topical drug delivery.Advancing tissue engineering by using electrospun nanofibers.Electrostatic micro- and nanoencapsulation and electroemulsification: a brief review.Current strategies for sustaining drug release from electrospun nanofibers.Therapeutic applications of electrospun nanofibers for drug delivery systems.Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug.Potential of Electrospun Nanofibers for Biomedical and Dental Applications.Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer.Preparation and characterization of multiactive electrospun fibers: poly-ɛ-carpolactone fibers loaded with hydroxyapatite and selected NSAIDs.Development of meloxicam-loaded electrospun polyvinyl alcohol mats as a transdermal therapeutic agent.Electrospun formulations containing crystalline active pharmaceutical ingredients.Preparation of electrospun polyurethane nanofiber mats for the release of doxorubicine.High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration.Cyclodextrin-based oral dissolving films formulation of taste-masked meloxicam.Fabrication and properties of capsicum extract-loaded PVA and CA nanofiber patches.PCL-forsterite nanocomposite fibrous membranes for controlled release of dexamethasone.Polymer-Based Electrospun Nanofibers for Biomedical Applications.Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization.A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.Electrospinning: processing technique for tissue engineering scaffoldingA Mucoadhesive Electrospun Nanofibrous Matrix for Rapid Oramucosal Drug Delivery
P2860
Q27022421-A1236591-2EC0-48F1-9745-E445C9017051Q27311607-5D34C022-71F5-4152-B1A3-B2A66504B377Q33247767-AEEC5AA4-F0A7-48EB-9727-BD4763E2FC9BQ33634560-F04EE811-C5FF-4701-A8B2-365FA8CB38FCQ34552997-72611E43-E8C9-495A-9660-385D9DDFA8EBQ34604290-759B7AE0-2A3A-4F9C-950B-9DED6F413F38Q34667748-A1DCA618-EFB7-4CA0-8A42-1C40835221EBQ35656903-8BC6A5BB-CA74-4694-925E-31F04A18D512Q35884678-F5103CAA-2863-499B-8FDF-04B96A884993Q36675915-542FCB4A-6894-438A-98DC-E8F53238C9CFQ36711164-22CC4E7C-AF65-4A4D-8B11-588F87354C32Q36978587-194A34BC-6912-41EE-ADFD-364A2F0FEF91Q37202807-566FB262-C27E-48CE-B109-540EC7DEF5CBQ37400058-4295D122-0FAF-4E1A-A31E-C9434F328809Q37585816-CCC75941-B773-4CBC-A3E2-AE7F3B6F0F4BQ38162821-1FEA2BCB-EE46-4786-ABCC-57B9BBF20559Q38257177-AAC0CBFC-8A4D-4D8A-8EFC-1FF44829CB5CQ41968403-B1D05377-3987-4953-B77E-1C1E25DE29FAQ42039804-91F49D6B-463E-4A43-9619-7CE6F350613DQ42226463-30E7431D-6807-4521-BF70-E82CAB308E2BQ43109651-247C04CA-EA35-4DC3-A842-FBEBA51F8799Q44858745-20FC2971-B922-4C23-BB90-C9C51CE656FBQ46360790-92E8BAE5-0711-4226-82E2-086E6DFBCAE9Q46570097-1E988740-7AEA-4E28-ACD3-4678F76DAC28Q47221117-839D1E70-B0CC-42CC-A9AE-0BC9CB21572CQ48260826-82ACEEC9-1D7C-4F8A-BF5C-12AB4EEF7D63Q50155160-9BA5D34E-9749-4225-8499-AEFB7FAECDE9Q50489717-ADF80668-E8CE-4C2A-AEAB-721398B6D64AQ51018585-F90415FD-704F-4E1C-84CC-3AF4BA0C4D25Q52574454-BD78B4F3-2750-476A-8B6A-422716C1C044Q53458423-2E094C94-F985-474E-9502-9B0D2A15E738Q53595925-94A9CE05-ADAD-49F9-A9CB-F889A78425F1Q57171681-1AC457D3-1809-4A2B-893C-F2AF07D0C941Q59019675-B358CE85-5848-4F8C-BC79-60C411C5A132
P2860
Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Preparation and characterizati ...... ted by electrostatic spinning.
@en
Preparation and characterizati ...... ted by electrostatic spinning.
@nl
type
label
Preparation and characterizati ...... ted by electrostatic spinning.
@en
Preparation and characterizati ...... ted by electrostatic spinning.
@nl
prefLabel
Preparation and characterizati ...... ted by electrostatic spinning.
@en
Preparation and characterizati ...... ted by electrostatic spinning.
@nl
P2093
P356
P1476
Preparation and characterizati ...... ted by electrostatic spinning.
@en
P2093
Geert Verreck
Iksoo Chun
Jef Peeters
Joel Rosenblatt
Marcus E Brewster
P304
P356
10.1023/A:1023450006281
P577
2003-05-01T00:00:00Z